Identification of Biomarkers of Shrinkage Modes After Neoadjuvant Therapy in HER-2 Positive Breast Cancer
{{output}}
Purpose: A nomogram to predict shrinkage modes after neoadjuvant therapy (NAT) was constructed in HER-2 positive (HER2 +) breast cancer. The value and mechanism of targeting long non-coding RNA (lncRNA) as efficacy prediction bio... ...
